A novel combination of metformin and resveratrol alleviates hepatic steatosis by activating autophagy through the cAMP/AMPK/SIRT1 signaling pathway
Crossref DOI link: https://doi.org/10.1007/s00210-023-02520-7
Published Online: 2023-05-20
Published Print: 2023-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Afshari, Havva
Noori, Shokoofe
Zarghi, Afshin
Text and Data Mining valid from 2023-05-20
Version of Record valid from 2023-05-20
Article History
Received: 8 February 2023
Accepted: 3 May 2023
First Online: 20 May 2023
Declarations
:
: Not applicable.
: The authors declare no competing interests.